1.2022.01-2025.12，国家自然科学基金（82172326），“细菌丝氨酸蛋白酶ClpP协同棘白菌素抗多重耐药热带念珠菌活性的机制研究”, 55万；在研

2. 2020.07-2022.06,上海市公共卫生重点学科（GWV-10.1-XK04），“病原微生物和生物安全”，200万；结题

3. 2020.10-2023.09，上海市优秀技术带头人（20XD1434500），“医院环境空气中重要传染病病原体实时检测系统研发”，40万元；在研

4. 2020.01-2023.12，国家自然科学基金（81971990），“金黄色葡萄球菌ClpP蛋白酶调控白念珠菌致病性及药物敏感性的作用机制”，54万；在研

5. 2018/06-2021/06，上海市科委临床重点项目（8411951500），“脓毒症早期快速病原体精准识别策略研究”，50万；结题

6. 2018/01-2021/06，十三五传染病重大专项子课题（2018ZX10003006-005-002），“纳米孔测序宏基因组分析方法在泌尿系感染临床样本中的验证”, 240万；结题

1.2022.01-2025.12，国家自然科学基金（82172326），“细菌丝氨酸蛋白酶ClpP协同棘白菌素抗多重耐药热带念珠菌活性的机制研究”, 55万；主持

2. 2020.07-2022.06,上海市公共卫生重点学科（GWV-10.1-XK04），“病原微生物和生物安全”，200万；主持

3. 2020.10-2023.09，上海市优秀技术带头人（20XD1434500），“医院环境空气中重要传染病病原体实时检测系统研发”，40万元；主持

4. 2020.01-2023.12，国家自然科学基金（81971990），“金黄色葡萄球菌ClpP蛋白酶调控白念珠菌致病性及药物敏感性的作用机制”，54万；主持

5. 2018/06-2021/06，上海市科委临床重点项目（8411951500），“脓毒症早期快速病原体精准识别策略研究”，50万；主持

6. 2018/01-2021/06，十三五传染病重大专项子课题（2018ZX10003006-005-002），“纳米孔测序宏基因组分析方法在泌尿系感染临床样本中的验证”, 240万；主持

近五年发表SCI论文（第一/通讯作者）

1. LinX,Yu Z, Liu Y, Li C, Hu H, Hu JC, Liu M, Yang Q, Gu P, Li J, Nandakumar KS, HuG,Zhang Q, Chen X, Ma H, Huang W, Wang G, Wang Y, Huang L, Wu W, Liu NN, ZhangC,Liu X, Zheng L, Chen P. Gut-X axis. iMeta. 2025 Feb 26;4(1):e270.doi:10.1002/imt2.270.1.

2. Wan F, Zhang M, Guo J, Lin H, Zhou X, WangL, WuW. A MALDI-TOF MS-based multiple detection panel of drugresistance-associatedmultiple single-nucleotide polymorphisms in Candidatropicalis. Microbiol Spectr. 2025 Jan 7;13(1):e0076424.doi:10.1128/spectrum.00764-24. 

3. Tang Y, Zhang J, Guan J, Liang W, PetassiMT,Zhang Y, Jiang X, Wang M, Wu W, Ou HY, Peters JE. Transposition withTn3-familyelements occurs through interaction with the host β-sliding clampprocessivityfactor. Nucleic Acids Res. 2024 Sep 23;52(17):10416-10430.doi:10.1093/nar/gkae674.

4. Wan S, Zhou A, Chen R, Fang S, Lu J, Lv N,WangC, Gao J, Li J, Wu W. Metagenomics next-generation sequencing (mNGS)revealsemerging infection induced by Klebsiella pneumoniaeniae. Int JAntimicrobAgents. 2024 Feb;63(2):107056. doi: 10.1016.

5. Yang S, Wan F, Zhang M, Lin H, Hu L, ZhouZ,Wang D, Zhou A, Ni L, Guo J, Wu W. In Vitro Activitiy of RezafungininComparison with Anidulafungin and Caspofungin against Invasive FungalIsolates(2017 to 2022) in China. J Fungi (Basel). 2024 May 31;10(6):397.doi:10.3390/jof10060397.

6. Guo J, Xiao C, Tian W, Lv L, Hu L, Ni L,WangD, Li W, Qiao D, Wu W. Performance of the Aspergillus galactomannanlateralflow assay with a digital reader for the diagnosis of invasiveaspergillosis: amulticenter study. Eur J Clin Microbiol Infect Dis. 2024Feb;43(2):249-257.doi: 10.1007/s10096-023-04724-4. 

7. Wang L, Gan D, Guo W, Zhu Y, Zhang M, ZhouA,Chen G, Wu W. Alteration of the gut microbiota changes during theone-yearAntarctic deployment in a group of Chinese Han population. BMCMicrobiol. 2024 Oct 23;24(1):427. doi: 10.1186/s12866-024-03569.

8. Liu M, Yang S, Wu S, Chen L, Li S, Li Z, Zhou M,Wang L, Xu H, Liu R, Fang Y, Huang W, Zhang M, Guo W, Dai Y, Ren Y, Guo H, WuW. Detection of pathogens and antimicrobial resistance genes directly fromurine samples in patients suspected of urinary tract infection by metagenomicsnanopore sequencing: A large-scale multi-centre study. Clin Transl Med. 2023Apr;13(4):e824. doi: 10.1002/ctm2.824.

9. Wu W, Ding J, Zheng X, Wang H, LiuNN.Editorial: New insights into the role of mycobiome in diseases. FrontCellInfect Microbiol. 2023 Jun 30;13:1240657. doi:10.3389/fcimb.2023.1240657. 

10. Lin H, Guo J, Li Y, Xiao C, Hu L, Chen H,Lu X,Wu W. In vitro antifungal susceptibility profile and genotypiccharacterizationof clinical Aspergillus isolates in Eastern China on behalf ofEastern ChinaInvasive Fungi Infection Group. Med Mycol. 2023 Sep4;61(9):myad082. doi:10.1093/mmy/myad082.

11. Guo J, Tian W, Lin H, Hu L, Gao X, Xia J,Yu H,Chen H, Li W, Wu W. Analytical and clinical validation of multiplexdropletdigital PCR assay for detecting pathogenic fungal infection in lungs. Mycology.2023Dec 29;15(1):110-119. doi: 10.1080/ 21501203. 2023.2296941.

12. Guo J, Chen J, Li T, Gao L, Jiang C, WuW.Integration of transcriptomics, proteomics, and metabolomics data forthedetection of the human pathogenic Prototheca wickerhamii from aOne Health perspective. Front CellInfect Microbiol. 2023 May5;13:1152198. doi: 10.3389/fcimb.2023.1152198.

13. Yang S, He L, Li K, Yu X, Ni L, Hu L, GuoJ, Biskup E, Tang L, Wu W.Efficacy of Active Rapid Molecular Screening and IPCInterventions onCarbapenem-Resistant Enterobacterales Infections inEmergency Intensive Care Unitswithout Enough Single-Room Isolation. InfectDrug Resist. 2023 Feb20;16:1039-1048. doi: 10.2147/IDR.S396331. 

14. Ziyi Zhou,Chendi Zhu, Margaret Ip, ManjiaoLiu,Zhaoqin Zhu, Ryon Liu, Xiaomin Li,Lingbing Zeng, WenjuanWu*.MolecularEpidemiology and Antifungal Resistance of Cryptococcus neoformansFromHumanImmunodeficiencyVirus-Negative and HumanImmunodeficiencyVirus-PositivePatientsin Eastern China. Front Microbiol. 2022 Jul5;13:942940. doi:10.3389 /fmicb.2022.942940.

15. Jian Guo, Jianbo Jian, Lili Wang,LijuanXiong, Huiping Lin, Ziyi Zhou,Eva C Sonnenschein, Wenjuan Wu*.GenomeSequences of Two Strains ofProtothecawickerhamii Provide Insight IntotheProtothecosis Evolution. Front Cell Infect Microbiol. 2022 Feb2;12:797017. doi:10.3389.

16.MinZhang; Ziyi Zhou; Dongjiang Wang; AipingZhou; Guobin Song; XingchunChen; JianGuo;Wenjuan Wu*; ComparativeEvaluation ofSensititre YeastOne andVITEK 2 against the Clinical andLaboratory StandardsInstitute M27-E4 ReferenceBroth Microdilution Method forthe AntifungalSusceptibility Testing of Cryptococcus neoformans and Cryptococcus gattii, MedicalMycology, 2022, myac009.

17. Yu Y, Liu C, Zhu C, Zhong H, Gu Z, Xu C,Pan C, Xu Z, Wu Z, Wu W, Lu L.A novel algorithm for diagnosis of invasivepulmonary aspergillosis based onpentraxin 3 gene polymorphisms and its adjustedvalue among autoimmune diseasespatients. Ann Transl Med. 2022Jan;10(1):17. doi: 10.21037/atm-21-4017. 

18. Donglai Liu , Haiwei Zhou , Teng Xu, Qiwen Yang, Xi Mo,  Sihong Xu , Wenjuan Wu*, Wenhong Zhang* , Chuntao Zhang*, Youchun Wang *.Multicenterassessment of shotgunmetagenomics for pathogen detection. EBioMedicine. 2021Dec;74:103649. doi:10.1016.

19. Qiuyuan Lin, Jingjing Wu , Liling Liu , Wenjuan Wu* , Xueen Fang , Jilie Kong .Sandwich/competitive immuno-sensors onmicro-interface for SARS-CoV-2 neutralizingantibodies. Anal Chim Acta.2021 Dec 1;1187:339144. doi:10.1016.

20. JianGuo, Min Zhang, Dan Qiao , Hui Shen ,Lili Wang , Dongjiang Wang ,Li Li , YunLiu , Huaiwei Lu , Chun Wang , Hui Ding, Shuping Zhou , WanqingZhou , YingjueWei , Haomin Zhang , Wei Xi , Yi Zheng ,Yueling Wang , Rong Tang, LingbingZeng* , Heping Xu *, Wenjuan Wu*.Prevalenceand AntifungalSusceptibility of Candida parapsilosis SpeciesComplex in EasternChina: A15-Year Retrospective Study by ECIFIG. Front Microbiol.2021 Mar4;12:644000.

21. Donghua Wen,Simin Yang, Guangbo Li,Qiankun Xuan , Wenzheng Guo ,Wenjuan Wu*.Sample-to-Answerand Routine Real-TimerRT-PCR: A Comparison ofDifferent Platforms forSARS-CoV-2 Detection. J MolDiagn.2021Jun;23(6):665-670.

22. Lili Wang,Wenzheng Guo, Hui Shen , JianGuo , Donghua Wen ,Yuetian Yu* , Wenjuan Wu*.Plasma Microbial Cell-FreeDNASequencing Technologyfor the Diagnosis of Sepsis in the ICU. Front MolBiosci. 2021 May28;8:659390.

23. YueSun, Jian Guo, Rong Chen, Liang Hu,Qihang Xia, Wenjuan Wu*,JinghuaWang*, Fupin Hu*. Multicenter evaluation ofthree different MALDI-TOFMSsystems for identification of clinically relevantfilamentous fungi. Med Mycol. 2021 Jan 4;59(1):81-86.

24. Xi Mo, Xueliang Wang, Zhaoqin Zhu, Yuetian Yu, Dong Chang, Xinxin Zhang, Dong Li, Fenyong Sun, Lin Zhou, Jin Xu, Hong Zhang, Chunfang Gao, Ming Guan, Yanqun Xiao, WenjuanWu*.QualityManagement for Point-Of-Care Testing ofPathogen Nucleic Acids: ChineseExpertConsensus. Front Cell Infect Microbiol.2021Oct 13;11:755508. doi:10.3389.

25. Min Zhang, Lili Wang, Siyuan Yu,GuixinSun, Han Lei *, Wenjuan Wu*.Status of Occupational Protectionin the COVID-19Fangcang Shelter Hospital inWuhan, China. Emerg Microbes Infect. 2020Dec;9(1):1835-1842.

26. Qiuyuan Lin, Donghua Wen, Jing Wu,LilingLiu, WenjuanWu *, Xueen Fang *,JilieKong*. Microfluidic Immunoassays forSensitive and Simultaneous DetectionofIgG/IgM/Antigen of SARS-CoV-2 within 15min. Anal Chem. 2020 Jul21;92(14):9454-9458.

  专利

1)  一种基于内参进行血浆微生物游离DNA宏基因组定量检测的方法及系统， 发明专利号：ZL 202210593922.2

2)  一种基于核酸质谱技术的热带念珠菌耐药基因检测方法, 发明专利号：ZL 202210649248.5

3)  通用开盖器，实用新型专利，授权号202222623550.1

4)  一种检测肺孢子菌特异性基因的方法及试剂盒，发明专利申请号：202311190920X

 书籍/标准：

1)  《WHO真菌重点病原体感染实验诊断与临床治疗》-上海科学技术出版社，ISBN 978-7-5478-6274-2,2023，主编

2)  《开启输血的盲盒》-上海科学普及出版社，ISBN978-7-5427-8531-2,2023，主编

3)  《方舱医院感染控制手册》-新型冠状病毒肺炎疫情防控实务-上海科学技术出版社, ISBN 978-7-5478-4829-6,2020，主编

4)  《细菌真菌耐药监测实用手册》-上海科学技术出版社, ISBN 978-7-5478-4983-5,2020，主编

5)  《细菌真菌药敏试验标准查询手册》-上海科学技术出版社, ISBN 978-7-5478-4549-3, 2020，主编

6)  《临床微生物检验标准化操作程序》-上海科学技术出版社，ISBN 978-7-5478-4503-5,2019，主编

7)  《Clinical Molecular Diagnostics》-英文Springer出版社, ISBN978-7-117-32038-2, 2021，编委

8)  T/CECS662G-2020 《医学生物安全二级实验室建筑技术标准》

9)  WS/T 807-2022 《临床微生物培养、鉴定和药敏检测系统的性能验证》

10) GB/T 42060-2022 《医学实验室样品采集、运送、接收和处理的要求》

11）T/SAME 001—2022《临床实验室 II 级生物安全柜管理要求》